Marie-Charlotte Desseroit1,2, Dimitris Visvikis3, Florent Tixier4,5, Mohamed Majdoub3, Rémy Perdrisot4,5, Rémy Guillevin5,6, Catherine Cheze Le Rest4,5, Mathieu Hatt3. 1. Nuclear Medicine, University Hospital, Poitiers, France. Marie-Charlotte.Desseroit@univ-brest.fr. 2. INSERM, UMR 1101, LaTIM, CHRU Morvan, University of Brest, 2 avenue Foch, 29609, Brest, France. Marie-Charlotte.Desseroit@univ-brest.fr. 3. INSERM, UMR 1101, LaTIM, CHRU Morvan, University of Brest, 2 avenue Foch, 29609, Brest, France. 4. Nuclear Medicine, University Hospital, Poitiers, France. 5. Medical school, EE DACTIM, University of Poitiers, Poitiers, France. 6. Radiology, University hospital, Poitiers, France.
Abstract
PURPOSE: Our goal was to develop a nomogram by exploiting intratumour heterogeneity on CT and PET images from routine (18)F-FDG PET/CT acquisitions to identify patients with the poorest prognosis. METHODS: This retrospective study included 116 patients with NSCLC stage I, II or III and with staging (18)F-FDG PET/CT imaging. Primary tumour volumes were delineated using the FLAB algorithm and 3D Slicer™ on PET and CT images, respectively. PET and CT heterogeneities were quantified using texture analysis. The reproducibility of the CT features was assessed on a separate test-retest dataset. The stratification power of the PET/CT features was evaluated using the Kaplan-Meier method and the log-rank test. The best standard metric (functional volume) was combined with the least redundant and most prognostic PET/CT heterogeneity features to build the nomogram. RESULTS: PET entropy and CT zone percentage had the highest complementary values with clinical stage and functional volume. The nomogram improved stratification amongst patients with stage II and III disease, allowing identification of patients with the poorest prognosis (clinical stage III, large tumour volume, high PET heterogeneity and low CT heterogeneity). CONCLUSION: Intratumour heterogeneity quantified using textural features on both CT and PET images from routine staging (18)F-FDG PET/CT acquisitions can be used to create a nomogram with higher stratification power than staging alone.
PURPOSE: Our goal was to develop a nomogram by exploiting intratumour heterogeneity on CT and PET images from routine (18)F-FDG PET/CT acquisitions to identify patients with the poorest prognosis. METHODS: This retrospective study included 116 patients with NSCLC stage I, II or III and with staging (18)F-FDG PET/CT imaging. Primary tumour volumes were delineated using the FLAB algorithm and 3D Slicer™ on PET and CT images, respectively. PET and CT heterogeneities were quantified using texture analysis. The reproducibility of the CT features was assessed on a separate test-retest dataset. The stratification power of the PET/CT features was evaluated using the Kaplan-Meier method and the log-rank test. The best standard metric (functional volume) was combined with the least redundant and most prognostic PET/CT heterogeneity features to build the nomogram. RESULTS: PET entropy and CT zone percentage had the highest complementary values with clinical stage and functional volume. The nomogram improved stratification amongst patients with stage II and III disease, allowing identification of patients with the poorest prognosis (clinical stage III, large tumour volume, high PET heterogeneity and low CT heterogeneity). CONCLUSION: Intratumour heterogeneity quantified using textural features on both CT and PET images from routine staging (18)F-FDG PET/CT acquisitions can be used to create a nomogram with higher stratification power than staging alone.
Entities:
Keywords:
Heterogeneity; NSCLC; PET/CT; Prognosis; Textural features
Authors: Jianhua Yan; Jason Lim Chu-Shern; Hoi Yin Loi; Lih Kin Khor; Arvind K Sinha; Swee Tian Quek; Ivan W K Tham; David Townsend Journal: J Nucl Med Date: 2015-07-30 Impact factor: 10.057
Authors: Balaji Ganeshan; Vicky Goh; Henry C Mandeville; Quan Sing Ng; Peter J Hoskin; Kenneth A Miles Journal: Radiology Date: 2012-11-20 Impact factor: 11.105
Authors: Gary J R Cook; Connie Yip; Muhammad Siddique; Vicky Goh; Sugama Chicklore; Arunabha Roy; Paul Marsden; Shahreen Ahmad; David Landau Journal: J Nucl Med Date: 2012-11-30 Impact factor: 10.057
Authors: Anne I J Arens; Esther G C Troost; Bianca A W Hoeben; Willem Grootjans; John A Lee; Vincent Grégoire; Mathieu Hatt; Dimitris Visvikis; Johan Bussink; Wim J G Oyen; Johannes H A M Kaanders; Eric P Visser Journal: Eur J Nucl Med Mol Imaging Date: 2013-12-18 Impact factor: 9.236
Authors: Linda Heijmen; Lioe-Fee de Geus-Oei; Johannes H W de Wilt; Dimitris Visvikis; Mathieu Hatt; Eric P Visser; Johan Bussink; Cornelis J A Punt; Wim J G Oyen; Hanneke W M van Laarhoven Journal: Eur J Nucl Med Mol Imaging Date: 2012-09-04 Impact factor: 9.236
Authors: Marie-Charlotte Desseroit; Florent Tixier; Wolfgang A Weber; Barry A Siegel; Catherine Cheze Le Rest; Dimitris Visvikis; Mathieu Hatt Journal: J Nucl Med Date: 2016-10-20 Impact factor: 10.057